‹ ›
MYP_062084
Basic Information
MT-WQ-IDL
Antimicrobial
Antiviral
Antiviral ▸ Anti-HIV ▸ Anti-HIV-1
Antiviral ▸ Antiviral mechanism ▸ Viral fusion inhibition
Standard
31 amino acids
C176H279N43O56S
Standard
Sequence
MTWEEWDKKIEEYTKKIEELIKKSQNQQIDL
Physicochemical Analysis
3925.42 Da
4.86
-2.49
-2.73
-0.0802
-1.39
0.69
-0.28
55.25
75.48
0.0968
12490.00
12490.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1675.70
-11.29
56.0
55.0
142.0
276.0
5.0
34.0
Structural Visualization
3D PDB MODEL
Readable PDBLast file check: 2026-11-19T01:36:37.730173+00:00. File readability does not guarantee 3D display.
Match index: Listed
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0340307 REVIEWED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Fusion-inhibitory peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-HIV-1 Fusion inhibition
HIV-1 IIIB; H9/HIV-1 IIIB cells; MT-2 cells
0.0012±0.0002 μM
IC50; cell-cell fusion inhibition
Mammalian: 30 h; Yeast: >20 h; E. coli: >10 h
RECORD: Rec_0374778 REVIEWED: NO
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Anti-HIV
HIV-1 NL4-3 V38A
FIRST PREV 1 ... 3 4 5
Showing 2 records · Page 5 of 5